Clinical trials and real-world data increasingly harness artificial intelligence and digital biomarkers to refine psychiatric treatment strategies. AI tools offer psychiatrists improved decision-making capabilities in complex disorders such as depression by analyzing patient data rapidly and precisely, leading to tailored interventions and optimized therapeutic outcomes. This technological integration marks a transformative shift in mental health care.